Despite their ubiquitous use, both frame-based and frameless stereotactic biopsies rely on preoperative images with intraoperative anatomical or fiducial registration to reach deep brain targets based on precalculated measurements in 3D space. 1,3,6,8,14,15,23 The primary limitations of these approaches are the inability to account for the shift of intracranial structures (reduces accuracy of the biopsy at the target), the inability to adapt to vital structures along the needle trajectory in real-time, and the lack of intraoperative imaging confirmation of the accuracy of the biopsy target. 5,7,13,22 Moreover, miscalculations or technical misalignment of hardware during biopsy can result in intraoperative morbidity. 6,10 Recent data indicate that the diagnostic accuracy of stereotaxy using conventional preoperative neuronavigation may be lower than previously reported (accuracy range 51%-91%). 3,4,8 To overcome these limitations, technology has been developed that now permits the integration of intraoperative MRI (iMRI) with frameless stereotaxy. The resolution and real-time feedback of this iMRI technology has been demonstrated in phantom experiments, 12,18 nonhuman primate studies, 16,17 drug infusion cannula placement, 2 and placement of deep brain stimulator leads. 9,11,20,21 Application of this technology to stereotactic brain biopsy could eliminate misdiagnosis secondary to faulty targeting, provide realtime adaptability for needle trajectory, confirm accurate biopsy cannula position, and provide immediate imaging of complications. To determine the feasibility, accuracy, and safety of real-time MRI-guided brain biopsy, we analyzed the results in consecutive brain biopsy cases using this paradigm.
Methods
PatientsConsecutive patients who underwent stereotactic brain abbreviatioNs GBM = glioblastoma multiforme; iMRI = intraoperative MRI. obJective The object of this study was to assess the feasibility, accuracy, and safety of real-time MRI-compatible frameless stereotactic brain biopsy. Methods Clinical, imaging, and histological data in consecutive patients who underwent stereotactic brain biopsy using a frameless real-time MRI system were analyzed. results Five consecutive patients (4 males, 1 female) were included in this study. The mean age at biopsy was 45.8 years (range 29-60 years). Real-time MRI permitted concurrent display of the biopsy cannula trajectory and tip during placement at the target. The mean target depth of biopsied lesions was 71.3 mm (range 60.4-80.4 mm). Targeting accuracy analysis revealed a mean radial error of 1.3 ± 1.1 mm (mean ± standard deviation), mean depth error of 0.7 ± 0.3 mm, and a mean absolute tip error of 1.5 ± 1.1 mm. There was no correlation between target depth and absolute tip error (Pearson product-moment correlation coefficient, r = 0.22). All biopsy cannulae were placed at the target with a single penetration and resulted in a diagnostic specimen in all cases. Histopathological evaluation of biopsy samples revealed dysembryoplastic neuroepithelial tumor (1 case),...